Bond Biosciences
Latest round
- Series B
Last raised
- Dec 2021
Total raised
- $12M
Investors
- 1
About Bond Biosciences
Founded in 2016, Bond Biosciences, Inc. specializes in therapeutics aimed at treating iron overload conditions.Bond Biosciences, Inc. specializes in the development of innovative non-absorbed oral therapeutics, particularly focusing on the treatment of iron-related diseases. Their flagship product, BBI-001, targets iron overload associated with Hereditary Hemochromatosis by binding dietary iron in the gastrointestinal tract to inhibit its absorption. This aims to prevent serious health complications linked to unmanaged iron overload, such as liver disease and cardiovascular issues.Bond Biosciences' revenue structure is anticipated to revolve around direct transactions with healthcare providers and potential partnerships with pharmaceutical distributors as the company advances its product offerings. It aims to establish a direct-to-consumer model for BBI-001, allowing access to the therapy upon regulatory approval. Revenue will be generated through sales of BBI-001 and may include service agreements or subscription models for ongoing treatment management.In December 2021, Bond Biosciences, Inc. As regulatory approvals are pursued, Bond Biosciences aims to expand its market reach, focusing on North America and potentially extending to other regions.
Who invested in Bond Biosciences
1 investor across 2 rounds
See all investors in Bond Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bond Biosciences
Who invested in Bond Biosciences?
Bond Biosciences has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bond Biosciences raised?
Bond Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Bond Biosciences last raise money?
Bond Biosciences's most recent round on record is a Series B, in Dec 2021.
What does Bond Biosciences do?
Founded in 2016, Bond Biosciences, Inc.
Where is Bond Biosciences headquartered?
Bond Biosciences is headquartered in New York, US.
Which VCs invest in companies like Bond Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Bond Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Bond Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.